Detalhe da pesquisa
1.
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers.
Am J Hematol
; 93(6): 729-735, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473209
2.
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
Lancet
; 387(10036): 2402-11, 2016 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27080498
3.
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Am J Hematol
; 91(4): 366-70, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689746
4.
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.
Blood Adv
; 7(15): 3936-3945, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026799
5.
Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial.
Lancet Haematol
; 6(9): e470-e479, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324600